Barcelona-based HealthTech startup, Sycai Medical, has raised €3 million in a recent investment round.
The funding will be used to develop and commercialize their AI-driven digital medical device that detects early cancer and pre-malignant lesions in the abdomen.
Sycai Medical's product automates the detection and characterization of pre-malignant lesions, enabling early diagnosis and patient monitoring.
The funds will also be used to expand the product's scope and obtain FDA approval.